Managers / Q4 2019 · view latest →
HANSEATIC MANAGEMENT SERVICES INC
CIK 0001128074 · 5600 WYOMING NE SUITE 220, ALBUQUERQUE, NM, 87109 · 5058282824
Summary
Hanseatic Management Services Inc reported $110M in U.S.-listed holdings across 232 positions for Q4 2019.
Its largest position, MSFT, represents 7.0% of the portfolio.
Compared with Q3 2019, the fund opened 71 new positions and exited 40.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.1% · $97M
- ETP · 6.4% · $7M
- REIT · 2.5% · $3M
- Other · 2.1% · $2M
- ADR · 0.5% · $510,000
- Other · 0.3% · $345,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| NVDANVIDIA Corp | NEW | +6.4K | 6.4K | +$2M | $2M |
| DYHTarget Corporation | NEW | +9.1K | 9.1K | +$1M | $1M |
| SGENUSDSeattle Genetics, Inc. | NEW | +9.4K | 9.4K | +$1M | $1M |
| WSTWest Pharmaceutical Svcs | NEW | +6.9K | 6.9K | +$1M | $1M |
| STTState Street Corp | NEW | +13.0K | 13.0K | +$1M | $1M |
| NBIXNeurocrine Biosciences Inc. | NEW | +9.0K | 9.0K | +$972,000 | $972,000 |
| RSReliance Steel & Aluminum | NEW | +7.5K | 7.5K | +$900,000 | $900,000 |
| AIZAssurant, Inc. | NEW | +6.5K | 6.5K | +$858,000 | $858,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $104M | 80 | May 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $79M | 117 | Jan 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $71M | 113 | Oct 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $67M | 114 | Jul 31, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $66M | 113 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $57M | 109 | Feb 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | Under review | 119 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $54,232 | 112 | Jul 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $44,464 | 106 | May 15, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2022 | Under review | 106 | Jan 26, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $37M | 100 | Nov 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $44M | 103 | Aug 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $58M | 137 | Apr 29, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $61M | 141 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $58M | 147 | Oct 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $53M | 147 | Jul 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $50M | 148 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $47M | 150 | Jan 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $44M | 177 | Oct 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $119M | 179 | Aug 10, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2020 | $94M | 198 | Apr 22, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $110M | 232 | Jan 29, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $98M | 201 | Oct 31, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $98M | 207 | Jul 19, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $96M | 262 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $74M | 248 | Jan 29, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.